Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ahment Hoke
Johns Hopkins University, Department: Neurology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Disarm Therapeutics, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The SFI’s are related in that their value could be affected by the research. Upon review by the Institution, it was determined that Dr. Hoke’s SFI’s could directly and significantly affect the design, conduct or reporting of his research under this award.
Mechanism of neuroprotection in chemotherapy induced peripheral neuropathy
Nervous system involvement has remained as one of the most important complications of chemotherapy despite development of novel and more effective anti-cancer therapies. Furthermore, there are no effective therapies that prevent or reverse axonal degeneration seen in chemotherapy- induced peripheral neuropathies. This study is aimed at understanding how peripheral nerves degenerate with paclitaxel, a widely used chemotherapy drug and develop new therapies to prevent it.
Filed on May 21, 2018.
Tell us what you know about Ahment Hoke's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Ahment Hoke”
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Ahment Hoke | Johns Hopkins University | Conflict of Interest | Disarm Therapeutics, Inc. | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.